Pharmaceuticals

Terra Sigillata

Category archives for Pharmaceuticals

The tagline is from Elaine D’Farley at Self magazine talking about the FDA’s then-pending approval of Allergan’s Latisse™ for cosmetic growth of longer, thicker eyelashes treatment of hypotrichosis of the eyelashes. While not expected until early 2009, Jacob Goldstein at the WSJ Health Blog clued me in to the approval last Friday (Allergan press release…

The Japanese scientist who grew fascinated by fungi as a boy is one among five of this years’ recipients of a Lasker Award. Endo was specifically given the Lasker~DeBakey Clinical Medical Research Award. Dr Akira Endo first isolated the hypocholesterolemic compound, mevastatin or compactin, from Penicillium citrinum. Compactin was the forerunner to the 3-hydroxy-3-methylglutaryl coenzyme…

Jake Young, the MD/PhD student blogging at Pure Pedantry, has a great post this week on the detection of a novel formulation of the erythropoiesis stimulating agent (ESA) erythropoietin in Riccardo Riccó, the Italian cyclist who was thrown out of the Tour de France. Jake’s post is a superb primer on the use of this…

Naw. This is more likely a case of an older person flushing some old prescription drugs down the toilet: In a February interview with The Associated Press, Mayor Robert Cluck said trace concentrations of one pharmaceutical had been found in treated drinking water, but he declined to name it. He said revealing the name in…

This whole “cosmeceutical” thing probably shouldn’t be in “Medicine & Health” but we did call your attention to today’s news item back on 27 July 2007: Drug maker Allergan announced at a stock analyst’s meeting this afternoon that it is filing a New Drug Application (NDA) for a cosmetic form of its anti-glaucoma drug bimatoprost…

GlaxoSmithKline to buy Sirtris

Just a little blurb in my local paper this morning that is making a big splash in the stock market: international pharma giant GSK is purchasing Cambridge, MA-based Sirtris Pharmaceuticals Inc. for an estimated US$720 million. Glaxo plans to bolster its pipeline with Sirtris’s experimental biotechnology treatments targeting aging-related diseases. In early trading, Sirtris shares…

Only time for a short post today but many news outlets are just now picking up on a 12 March WaPo article by David Segal on the 10th anniversary of the US FDA approval of the erectile dysfunction drug, Viagra. As we noted in yesterday’s post, the active ingredient in Viagra, sildenafil, is so popular…

The safety and effectiveness of medicines and other health products is dependent upon their proper use, particularly the proper route of administration. There are reasons why products are labeled as “for topical use only” or “do not swallow” – two recent warnings from the US FDA illustrate these issues. Allergic Reactions with Use/Misuse of Denture…

This issue was brought up by my fellow blogger, Joseph at Corpus Callosum, following an article in yesterday’s LA Times. For those not familiar with the concept or countries other than the US where laws may differ, generic drugs are those with the same active chemical as the originally-approved “brand name” drug. The original drug…

Yes! “A Call for a Presidential Debate on Science & Technology.” Imagine a presidential debate focused solely on issues of science and technology as they relate to medicine, international competitiveness, terrorism, public health, embryonic stem cell research, bioethics of genotyping and other molecular diagnostics, research policy/funding and job creation, or minimization of health disparities, among…